# A summary of the current circumstances of migraineurs in China: a review of the GBD2019 database

**Authors:** Changchang Ying, Qijun Yu, Qingling Zhai, Yonghui Pan

PMC · DOI: 10.3389/fnhum.2025.1626607 · Frontiers in Human Neuroscience · 2025-10-10

## TL;DR

This paper reviews migraine prevalence and impact in China using global health data to guide future research and treatment.

## Contribution

The paper provides an updated analysis of migraine burden in China using the GBD2019 database.

## Key findings

- Migraine significantly affects quality of life and health in China.
- GBD2019 data highlights the need for improved prevention and treatment strategies.
- The study reveals recent trends in migraine incidence and disability in China.

## Abstract

Migraine is a common, chronic and recurrent neurovascular disorder ranked by the WHO as one of the 20 most disabling conditions worldwide. Frequent and severe headaches can significantly impair patients’ quality of life, learning capacity, and physical and mental health. On the basis of the Global Burden of Disease (GBD) 2019 database, this article reviews the incidence, disability and treatment of migraine in China in recent years. This study aims to analyze the current status of migraine patients in China and to inform future research on its epidemiology, prevention, and treatment.

## Linked entities

- **Diseases:** migraine (MONDO:0005277)

## Full-text entities

- **Diseases:** Migraine (MESH:D008881), headaches (MESH:D006261), neurovascular disorder (MESH:D013901)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12549686/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12549686/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12549686/full.md

---
Source: https://tomesphere.com/paper/PMC12549686